Inhibition of DNMT3B and PI3K/AKT/mTOR and ERK Pathways as a Novel Mechanism of Volasertib on Hypomethylating Agent-Resistant Cells-Reference-Cited by-同舟云学术

Inhibition of DNMT3B and PI3K/AKT/mTOR and ERK Pathways as a Novel Mechanism of Volasertib on Hypomethylating Agent-Resistant Cells

Published:2022-11-16 Issue:3 Volume:31 Page:319-329
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomol Ther (Seoul)

Author:

Choi Eun-Ji¹,Koo Bon-Kwan¹,Hur Eun-Hye¹,Moon Ju Hyun¹,Kim Ji Yun¹,Park Han-Seung¹,Choi Yunsuk¹,Lee Kyoo-Hyung¹,Lee Jung-Hee¹,Choi Eun Kyung²,Lee Je-Hwan¹

Affiliation:

1. Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

2. Asan Preclinical Evaluation Center for Cancer Therapeutics, Asan Medical Center, Seoul 05505, Republic of Korea

Funder

Asan Institute for Life Sciences, Asan Medical Center

Korea Health Industry Development Institute

Ministry of Health and Welfare

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2023/031/BT031-03-319.pdf

Reference38 articles.

1. Identification of volasertib-resistant mechanism and evaluation of combination effects with volasertib and other agents on acute myeloid leukemia

2. Interplay Between the Cell Cycle and Double-Strand Break Response in Mammalian Cells

3. Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast Cancer

4. Cai, X. P., Chen, L. D., Song, H. B., Zhang, C. X., Yuan, Z. W. and Xiang, Z. X. (2016) PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells. Am. J. Transl. Res. 8, 4172-4183.

5. Cooperative effects of genes controlling the G2/M checkpoint

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma;International Journal of Nanomedicine;2024-08

2. Downregulating DNA methyltransferase 3B by suppressing the PI3K/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide;Molecular Neurobiology;2024-02-17

3. Downregulated the expression of DNMT3B by suppressing PI3K/Akt signaling pathway and enhances the chemosensitivity of glioblastoma to temozolomide.;2023-10-03